V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 280006542 | 280004008 | 1.8 | null | Palliative (P) | 2014-02-22 | 2014-02-22 | Cetuximab + CISPLATIN + FLUOROURACIL | 2 | N | 280021151 | CAPECITABINE + CARBOPLATIN |
| 280006543 | 280004008 | 1.86 | 70.8 | Palliative (P) | null | 2015-05-06 | VAC | N | N | 280021151 | PAZOPANIB |
| 280006544 | 280004008 | 1.79 | 131.8 | Curative (C) | 2015-08-09 | 2015-08-16 | DE-ESCALATE TRIAL | null | N | 280021151 | CISPLATIN + VINORELBINE |
| 280006545 | 280004009 | 1.87 | 103 | Neo-adjuvant (N) | 2014-11-27 | 2015-01-04 | ECX | N | Y | 280021219 | VIDE |
| 280006546 | 280004009 | 1.54 | 67.5 | Palliative (P) | 2019-01-24 | 2019-01-24 | CARBOPLATIN + GEMCITABINE | Y | null | 280021219 | TRABECTEDIN |
| 280006547 | 280010144 | 1.84 | 87 | Curative (C) | 2014-03-05 | 2014-03-09 | GemCarbo Days 1+8 | 02 | N | 280021294 | DE-ESCALATE TRIAL |
| 280006548 | 280010144 | null | null | Curative (C) | 2018-09-06 | 2018-09-06 | Cisplatin + Pemetrexed | N | null | 280021294 | EPSSG |
| 280006549 | 280010144 | 1.56 | 43 | Palliative (P) | 2018-03-11 | 2018-03-11 | IVADo | 02 | N | 280021294 | TRABECTEDIN |
| 280006550 | 280004010 | 1.61 | 110 | Palliative (P) | 2018-09-28 | 2018-10-02 | Paclitaxel 80mg/m2 day 1 8 15 | N | N | 280021334 | GEMCARBO |
| 280006551 | 280004010 | 1.86 | 94 | Not known (9) | 2012-11-27 | 2012-11-28 | Cetuximab+Cisplatin+FU (> Cycle 2) | 02 | N | 280021334 | LENALIDOMIDE |
| 280006552 | 280004010 | 1.47 | 70.8 | null | 2015-05-11 | 2015-08-30 | Carboplatin + Pemetrexed | N | N | 280021334 | MELPHALAN |
| 280006553 | 280004011 | 1.72 | 75 | Not known (9) | 2018-11-05 | 2018-11-11 | EW EuroEwing 2012 Arm A VIDE | N | N | 280021375 | LENALIDOMIDE |
| 280006554 | 280004012 | 1.68 | null | null | null | 2018-12-24 | CREATE TRIAL | 02 | null | 280021411 | CAPECITABINE + CISPLATIN |
| 280006555 | 280008179 | 1.79 | 102 | Palliative (P) | null | 2017-12-21 | EURO-EWING | null | null | 280021437 | IFOSFAMIDE |
| 280006556 | 280004013 | 1.58 | 59.9 | Curative (C) | 2016-06-11 | 2016-06-26 | GemCarbo Days 1+8 | N | N | 280021480 | RMS 2005 TRIAL |
| 280006557 | 280004014 | null | 57.6 | Curative (C) | 2015-05-31 | 2015-05-31 | PEMBROLIZUMAB | null | null | 280021499 | CYCLOPHOSPHAMIDE + DOXORUBICIN + ETOPOSIDE + IFOSFAMIDE + VINCRISTINE |
| 280006558 | 280004015 | 1.78 | 110 | Neo-adjuvant (N) | 2015-12-02 | 2015-12-16 | Capecitabine | 2 | N | 280021501 | CYCLOPHOSPHAMIDE + VINCRISTINE |
| 280006559 | 280004016 | 1.59 | 137 | null | 2014-12-22 | 2014-12-24 | GemCarbo Days 1+8 | N | N | 280021558 | DE-ESCALATE TRIAL |
| 280006560 | 280004016 | 1.82 | 93.6 | Palliative (P) | 2014-10-19 | 2014-11-15 | DE-ESCALATE TRIAL | N | N | 280021558 | LIPOSOMAL DOXORUBICIN |
| 280006561 | 280004017 | 1.6 | 55.6 | Curative (C) | 2013-11-10 | 2013-11-13 | Capecitabine | 02 | N | 280021729 | EURO-EWING |
| 280006562 | 280004017 | 1.79 | null | Palliative (P) | null | 2014-06-29 | VIDE | N | N | 280021729 | TRABECTEDIN |
| 280006563 | 280004018 | 1.8 | 0 | Palliative (P) | 2015-12-16 | 2015-12-16 | CARBO + FLUOROURACIL | 2 | N | 280021738 | TRABECTEDIN |
| 280006564 | 280004019 | 1.64 | 85.4 | Palliative (P) | 2015-04-28 | 2015-09-01 | Carboplatin + Liposomal Doxorubicin | 02 | N | 280021800 | IVADO |
| 280006565 | 280004019 | 1.83 | 76.4 | Palliative (P) | 2017-08-18 | 2017-08-18 | EW EuroEwing 99 : VIDE | N | N | 280021800 | ECF |
| 280006566 | 280004020 | null | 67.9 | Palliative (P) | null | 2016-08-11 | FLUOROURACIL + MITOMYCIN + RT | null | null | 280021896 | PEMBROLIZUMAB |
| 280006567 | 280004020 | 1.5 | 41.5 | Curative (C) | 2017-05-11 | 2017-06-04 | ECX | N | N | 280021896 | COMPARE TRIAL |
| 280006568 | 280004021 | 1.76 | null | Curative (C) | null | 2014-09-03 | STS Rhabdomyosarcoma RMS 2005 IVA | null | null | 280021930 | CISPLATIN + ETOPOSIDE |
| 280006569 | 280008184 | null | 74.55 | Palliative (P) | 2015-04-24 | 2015-04-26 | Capecitabine (21days) + Carboplatin | N | null | 280021971 | CARBO + FLUOROURACIL |
| 280006570 | 280004022 | null | 48 | Neo-adjuvant (N) | null | 2014-04-18 | Trabectedin | null | null | 280021985 | CISPLATIN + FLUOROURACIL + RT |
| 280006571 | 280004022 | 1.71 | 71.3 | Curative (C) | 2016-01-07 | 2016-02-10 | Cisplatin + Pemetrexed | Y | Y | 280021985 | DE-ESCALATE TRIAL |
| 280006572 | 280004023 | 1.72 | 66.3 | Palliative (P) | 2016-08-23 | 2016-08-24 | CAPECITABINE + EPIRUBICIN + OXALIPLATIN | N | N | 280022020 | CISPLATIN + FLUOROURACIL + RT |
| 280006573 | 280004024 | 1.74 | 0 | Adjuvant (A) | 2016-05-23 | 2016-06-13 | Capecitabine (14 days)+Carboplatin | 02 | N | 280022082 | IFOSFAMIDE + LIPOSOMAL DOXORUBICIN |
| 280006574 | 280004025 | 1.7 | 88 | Palliative (P) | 2017-06-12 | 2017-06-26 | Capecitabine + Oxaliplatin 21day | 2 | N | 280022092 | CISPLATIN + PEMETREXED |
| 280006575 | 280004025 | 1.71 | 104.4 | Curative (C) | 2017-07-31 | 2017-08-16 | Gemcitabine 1000mg/m2 D1 8 15 | N | N | 280022092 | COMPARE TRIAL |
| 280006576 | 280010146 | 1.7 | 85.1 | Curative (C) | 2014-12-15 | 2014-12-19 | VAC | N | N | 280022125 | EURO-EWING |
| 280006577 | 280004026 | 1.57 | 50.6 | Palliative (P) | null | 2016-10-09 | Capecitabine | N | Y | 280022132 | CEDIRANIB |
| 280006578 | 280008187 | 1.64 | 79 | Palliative (P) | 2017-10-14 | 2017-11-02 | PATHOS Trial | N | N | 280022187 | DOXORUBICIN + OLARATUMAB |
| 280006579 | 280008187 | 1.78 | 66 | null | null | 2016-11-01 | Capecitabine 35days + RT | null | null | 280022187 | IVADO |
| 280006580 | 280004027 | null | null | Adjuvant (A) | 2016-05-23 | 2016-05-31 | STS Rhabdomyosarcoma RMS 2005 IVA | N | N | 280022353 | CAPECITABINE |
| 280006581 | 280004027 | 0 | 99.8 | Adjuvant (A) | 2017-06-17 | 2017-06-17 | Capecitabine | 02 | N | 280022353 | CISPLATIN + DOXORUBICIN |
| 280006582 | 280004027 | 1.83 | null | Curative (C) | 2014-01-06 | 2014-01-30 | ECX | 1 | Y | 280022353 | COMPARE TRIAL |
| 280006583 | 280004028 | 1.63 | 0 | Palliative (P) | 2013-09-06 | 2013-09-11 | VIDE | N | N | 280022476 | DOCETAXEL + GEMCITABINE |
| 280006584 | 280004028 | 1.75 | null | Neo-adjuvant (N) | 2015-05-06 | 2015-05-06 | OCTREOTIDE | null | null | 280022476 | VIDE |
| 280006585 | 280004029 | null | null | null | null | 2016-10-23 | GemCarbo Days 1+8 | Y | N | 280022485 | CARBO + FLUOROURACIL |
| 280006586 | 280004030 | 1.8 | null | Palliative (P) | 2015-07-23 | 2015-07-24 | Doxorubicin + Olaratumab | N | null | 280022491 | DOXORUBICIN + OLARATUMAB |
| 280006587 | 280004031 | null | null | Palliative (P) | 2015-01-01 | 2015-01-05 | Cisplatin + Fluorouracil + RT 5day | null | null | 280022500 | DOXORUBICIN + OLARATUMAB |
| 280006588 | 280004031 | 1.62 | 81 | Curative (C) | 2014-08-04 | 2014-08-28 | FLUOROURACIL + IRINOTECAN | N | N | 280022500 | ETOPOSIDE + IFOSFAMIDE |
| 280006589 | 280004032 | 1.69 | 81 | Palliative (P) | 2015-03-10 | 2015-03-11 | Doxorubicin + Olaratumab | N | N | 280022533 | VIDE |
| 280006590 | 280004033 | 1.68 | 53.3 | Palliative (P) | null | 2017-10-27 | CISPLATIN + FLUOROURACIL + RT | 02 | null | 280022566 | AC |
| 280006591 | 280004034 | 1.61 | null | Palliative (P) | 2015-06-10 | 2015-06-10 | Erlotinib | N | N | 280022621 | PACLITAXEL |